Harnessing proprietary editing platforms to develop next-generation therapeutics for life-threatening diseases.
Independently developed liver-targeted and non-liver-targeted delivery systems for efficient and precise RNA therapeutics delivery.
Multi-layered and multi-modal RNA editing technologies enabling safe and precise modifications at the RNA level.
An AI-powered platform for identifying key RNA regulatory and protein function sites, expanding the frontier of oligonucleotide therapeutics.